American Healthcare REIT, Inc. AHR
52.02
(0.29)
(0.55%)
as of 25 Sep
- Market cap
- $11.5B
- P/E
- 76.5×
Follow AHR
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 114.78 |
P/S ratio |
0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 1.79 | 3.46 |
P/FCF ratio |
4.76 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 | 16.47 | 36.16 |
P/Operating CF |
33.88 | 33.88 | 33.88 | 33.88 | 33.88 | 33.88 | 33.88 | 62.39 | 141.66 |
P/B ratio |
0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 1.61 | 2.33 |
Price to Tangible BV |
0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 1.95 | 2.72 |
EV/Sales |
1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 2.56 | 4.08 |
EV/EBITDA |
10.51 | 10.51 | 10.51 | 10.51 | 10.51 | 10.51 | 10.51 | 15.07 | 23.69 |
EV/Operating CF |
34.00 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 | 30.07 | 31.29 |
EV/FCF |
18.28 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 | 23.49 | 42.64 |
Quick Ratio |
— | 0.08 | 0.05 | 0.27 | 0.18 | 0.16 | 0.19 | 0.35 | 0.41 |
Current Ratio |
— | 0.08 | 0.05 | 0.27 | 0.18 | 0.16 | 0.19 | 0.35 | 0.41 |
Net Debt/EBITDA |
0.00 | 8.67 | 1.84 | 6.90 | 12.30 | 7.90 | 7.77 | 4.50 | 3.60 |
Debt/Assets |
0.00% | 32.56% | 39.58% | 52.01% | 51.43% | 53.48% | 56.10% | 38.00% | 28.58% |
Debt/Equity |
0.00 | 0.52 | 0.72 | 1.63 | 1.34 | 1.63 | 1.80 | 0.74 | 0.46 |
Asset Turnover |
0.00 | 0.19 | 1.25 | 0.58 | 0.33 | 0.35 | 0.40 | 0.46 | 0.46 |
Operating CF/Net income |
22.93 | (1.85) | (23.66) | 101.32 | (0.37) | (1.82) | (1.38) | (4.66) | 4.22 |
Capex/Depreciation |
(0.08) | (0.13) | (0.65) | (0.89) | (0.48) | (0.10) | 0.34 | 0.22 | (0.35) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | (0.87%) | 0.27% | (3.42%) | (4.89%) | (4.78%) | (2.03%) | 2.46% | |
| 0.00% | (1.86%) | (0.51%) | 0.10% | (1.22%) | (1.74%) | (1.53%) | (0.83%) | 1.41% | |
ROIC |
0.00% | (0.13%) | 5.04% | 2.24% | 0.38% | 1.34% | 1.14% | 2.09% | 2.15% |
Return on Tangible Assets |
0.00% | (1.89%) | (1.02%) | 0.14% | (2.04%) | (3.53%) | (3.20%) | (1.37%) | 1.90% |
Average Days of Receivables |
0.00 | 48.62 | 1.38 | 36.54 | 34.95 | 30.54 | 36.25 | 37.21 | 33.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
13.01% | 10.86% | 2.43% | 2.17% | 3.37% | 2.64% | 2.55% | 2.30% | 2.60% |
Intangible Assets out of Total Assets |
0.00 | 0.08 | 0.07 | 0.07 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 |
Share Based Compensation of Revenue |
0.39% | 0.22% | 0.24% | (0.10%) | 0.75% | 0.24% | 0.29% | 0.48% | 0.65% |
Graham Net Nets |
(3.29) | (3.29) | (3.29) | (3.29) | (3.29) | (3.29) | (3.29) | (0.50) | (0.22) |
Graham Number |
2.28 | 0.00 | 0.00 | 10.10 | 0.00 | 0.00 | 0.00 | 0.00 | 13.66 |
Earnings Yield |
(8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (0.95%) | 0.87% |
Free Cash Flow Yield |
20.99% | 20.99% | 20.99% | 20.99% | 20.99% | 20.99% | 20.99% | 6.07% | 2.77% |
Revenue per Share |
1.20 | 1.54 | 6.72 | 27.66 | 25.60 | 24.97 | 28.26 | 15.85 | 13.61 |
Operating CF per Share |
0.45 | 0.28 | 0.65 | 4.87 | 0.36 | 2.25 | 1.49 | 1.35 | 1.77 |
Capex per Share |
(0.04) | (0.08) | (0.50) | (2.57) | (1.50) | (0.35) | 1.28 | 0.38 | (0.47) |
Free Cash Flow per Share |
0.41 | 0.20 | 0.14 | 2.30 | (1.14) | 1.89 | 2.77 | 1.73 | 1.30 |
Cash per Share |
0.00 | 0.27 | 0.09 | 3.38 | 2.51 | 1.70 | 1.37 | 0.94 | 0.91 |
Shareholders Equity per Share |
0.00 | 10.17 | 3.24 | 23.00 | 35.08 | 23.82 | 21.58 | 17.64 | 20.24 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 10.17 | 3.24 | 23.00 | 35.08 | 23.82 | 21.58 | 17.64 | 20.24 |
Free Cash Flow |
11.28 | 11.17 | 25.85 | 103.38 | (57.28) | 124.55 | 183.28 | 225.42 | 216.09 |
Working Capital |
— | (290.14) | (409.39) | (761.56) | (1,166.49) | (1,276.22) | (1,190.71) | (612.45) | (511.44) |
Capital Expenditures |
(1.12) | (4.26) | (91.61) | (115.78) | (75.20) | (23.22) | 84.74 | 49.33 | (78.35) |
Net Current Asset Value |
0.00 | (312.86) | (457.79) | (1,923.71) | (2,575.23) | (2,969.53) | (2,876.44) | (1,849.71) | (1,709.54) |
EV/EBIT |
47.24 | 47.24 | 47.24 | 47.24 | 47.24 | 47.24 | 47.24 | 40.84 | 56.26 |
Capex to Sales |
0.03 | 0.05 | 0.07 | 0.09 | 0.06 | 0.01 | (0.05) | (0.02) | 0.03 |
Net Profit Margin |
1.62% | (9.89%) | (0.41%) | 0.17% | (3.73%) | (4.95%) | (3.83%) | (1.83%) | 3.09% |
Price to Operating Income |
12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 28.64 | 47.72 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.00 | 0.05 | 0.16 | 0.06 | 0.04 | 0.06 | 0.07 | 0.07 | 0.05 |
Cash ROIC |
0.00% | (82.88%) | (75.58%) | (73.57%) | (82.51%) | (80.99%) | (81.46%) | (77.20%) | (76.81%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 154.27 | 19.27 | 10.37 | 12.63 | 11.56 | 10.45 | 10.88 |
Accounts Payable Turnover |
0.00 | 0.00 | 27.06 | 9.01 | 5.58 | 6.21 | 6.41 | 6.81 | 6.41 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 360.26 | 12.04 | 69.25 | 64.24 | 66.36 | 56.84 | 55.23 | 62.86 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 7.93 | 64.58 | 123.67 | 130.14 | 161.44 | 198.24 | 207.71 |
Average Payables |
— | — | 37.02 | 113.86 | 191.40 | 215.98 | 243.37 | 250.61 | 288.03 |
Average Assets |
— | 448.19 | 982.35 | 2,151.63 | 3,907.64 | 4,683.52 | 4,682.32 | 4,533.00 | 4,957.14 |
Average Common Equity |
— | — | 573.88 | 812.28 | 1,395.66 | 1,662.31 | 1,496.55 | 1,864.64 | 2,832.28 |
Columns are period end dates